1. Deterioration rates in Virtual Reality Therapy: An individual patient data level meta-analysis
- Author
-
Paul Pauli, Andreas Mühlberger, Kataryzna Wyka, Wenceslao Peñate Castro, Stéphane Bouchard, Amanda A. Benbow, Rosa M. Baños, Isabel Kampann, S. Quero, Verónica Guillén, Paul M. G. Emmelkamp, Georgina Cárdenas, Max M. North, Giuseppe Riva, Per Carlbring, Hunter G. Hoffman, Desirée Colombo, Cristina Botella, JoAnn Difede, Javier Fernández-Álvarez, Page L. Anderson, Alexander Rozental, Ramona Moldovan, Juana Bretón-López, Miquel Tortella-Feliu, and Azucena García-Palacios
- Subjects
Adult ,Male ,050103 clinical psychology ,medicine.medical_specialty ,Adolescent ,deterioration rates ,Virtual reality ,Individual patient data analysis ,law.invention ,Odds ,03 medical and health sciences ,Young Adult ,Anxiety disorders ,Deterioration rates ,Clinical Psychology ,Psychiatry and Mental Health ,0302 clinical medicine ,Randomized controlled trial ,anxiety disorders ,law ,Internal medicine ,medicine ,Odds Ratio ,Humans ,Settore M-PSI/01 - PSICOLOGIA GENERALE ,0501 psychology and cognitive sciences ,Aged ,Virtual Reality Exposure Therapy ,05 social sciences ,individual patient data analysis ,Odds ratio ,Middle Aged ,Anxiety Disorders ,Confidence interval ,Virtual reality therapy ,030227 psychiatry ,Psychiatry and Mental health ,Meta-analysis ,Anxiety ,Marital status ,virtual reality ,Female ,medicine.symptom ,Psychology - Abstract
Ample evidence supports the use of Virtual Reality (VR) for anxiety disorders. Nonetheless, currently there is no evidence about moderators or potential negative effects of VR treatment strategies. An Individual Patient Data (IPD) approach was employed with 15 retrieved datasets. The current study sample was composed of 810 patients. Randomized control trials (RCTs) for each primary outcome measure were performed, in addition to moderator analyses of the socio-demographic variables. Deterioration rates were 14 patients (4.0%) in VR, 8 (2.8%) in active control conditions, and 27 (15%) in the WL condition. With regard to receiving treatment, patients in a waiting list control condition had greater odds of deteriorating than in the two active conditions, odds ratios (ORs) 4.87, 95% confidence interval (CI) [0.05, 0.67]. In the case of the socio-demographic variables, none of them were associated with higher or lower odds of deterioration, with the exception of marital status in the WL condition; married people presented a significantly lower probability of deterioration, OR 0.19, 95% CI [0.05, 0.67]. Finally, when comparing pooled effects of VR versus all control conditions, the OR was 0.61 (95% CI 0.31–1.23) in favor of VR, although this result was not statistically significant. This study provides evidence about the deterioration rates of a therapeutic VR approach, showing that the number of deteriorated patients coincides with other therapeutic approaches, and that deterioration is less likely to occur, compared to patients in WL control groups.
- Published
- 2019